Adam Schiff, Tim Kaine Introduce Bill To Protect Caribbean Drug Traffickers From Trump Strikes

Sens. Adam Schiff (D-Calif.) and Tim Kaine (D-Va.) introduced a resolution on Friday aimed at halting U.S. military strikes on drug trafficking operations in the Caribbean, saying the actions were launched without congressional approval.

The measure, filed under the War Powers Act, would prohibit use of the military against non-state groups involved in drug trafficking unless Congress authorizes it. War powers resolutions are privileged, meaning the Senate must take up the measure for debate and a vote.

The move follows two recent military strikes in the Southern Caribbean Sea—on Sept. 2 and Sept. 15—that targeted vessels that were carrying narcotics. Democratic lawmakers say they have not received key details about the incidents, including who was on board, the cargo, and the legal basis for lethal force.

President Donald Trump has said the vessels belonged to “extraordinarily violent drug trafficking cartels and narcoterrorists” operating out of Venezuela. He said the boats were carrying narcotics bound for the United States, calling them a direct threat to U.S. national security and vital interests.

“If you are transporting drugs that can kill Americans, we are hunting you,” Trump said after the Sept. 15 operation, which killed three people. He added there was “recorded evidence” that drugs were on board, including large bags of cocaine and fentanyl scattered in the water after the strike.

“Congress alone holds the power to declare war,” Schiff said in announcing the resolution. “And while we share with the executive branch the imperative of preventing and deterring drugs from reaching our shores, blowing up boats without any legal justification risks dragging the United States into another war and provoking unjustified hostilities against our own citizens.”

Kaine alleged the Trump administration had failed to explain why standard interdiction methods were not used.

“President Trump has no legal authority to launch strikes or use military force in the Caribbean or elsewhere in the Western Hemisphere,” Kaine said, adding that “Congress simply cannot let itself be stiff-armed as this administration continues to flout the law.”

The White House has said the earlier strike on Sept. 2 targeted the operations of Tren de Aragua, a Venezuelan transnational gang designated as a foreign terrorist organization, and that it was conducted in defense of U.S. national interests.

Keep reading

Venezuela Announces Capture of Alleged DEA Agent With Massive Drug Shipment

Venezuelan authorities announced on Wednesday the seizure of nearly 3.7 metric tons of cocaine and the arrest of several individuals, including a man they claim is a U.S. Drug Enforcement Administration (DEA) agent.

Interior Minister Diosdado Cabello said security forces intercepted a speedboat in the waters off Falcón state on September 14, carrying 100 sacks of cocaine and 2,400 liters of fuel. The operation, which Cabello described as “clean,” ended with five arrests. The detainees were identified as Joel Luis Rodríguez Ramos, Jesús Antonio Quilarte Carreño, Jhonny José Salazar Gutiérrez, Carlos Alberto Bravo Lemus, and Levi Enrique López, who Cabello alleged is linked to the DEA.

According to Cabello, the detainees confessed the shipment was part of a “false flag operation” designed to incriminate Venezuela in international drug trafficking and justify external aggression. “The four detainees are saying they work for the DEA,” Cabello told state television, calling the alleged plan a “maneuver for destabilization.”

Keep reading

Democrats Introduce Bill To Prevent Strikes on Narcoterrorists

Senate Democrats have introduced a new resolution in an attempt to prevent military action against drug smugglers in the Caribbean.

Sens. Adam Schiff and Tim Kaine introduced a resolution on Friday to prevent further military strikes, on the basis that Congressional approval has not been sought.

The resolution, filed under the War Powers Act, would prevent the use of the US military against non-state groups taking part in drug smuggling unless Congress approves.

Because War Powers resolutions are privileged, the Senate will be forced to consider the resolution for a vote.

On Friday, the US military carried out a third lethal strike on a boat alleged to be carrying drug smugglers in the Caribbean.

In a post on Truth Social, President Trump said, “On my Orders, the Secretary of War ordered a lethal kinetic strike on a vessel affiliated with a Designated Terrorist Organization conducting narcotrafficking in the [United States Southern Command] area of responsibility,” which intelligence had confirmed was “trafficking illicit narcotics.”

The strike took place in international waters.

According to President Trump, “three male narcoterrorists” were killed. The President did not say which group the men belonged to.

The President ended his social-media post with a warning: “STOP SELLING FENTANYL, NARCOTICS, AND ILLEGAL DRUGS IN AMERICA, AND COMMITTING VIOLENCE AND TERRORISM AGAINST AMERICANS.”

Keep reading

Democratic Congresswoman Calls Out GOP Colleague’s Marijuana Arrest As He Works To Upend D.C. Sentencing Reform Law

A Democratic congresswoman is accusing a Republican lawmaker of hypocrisy for sponsoring legislation to upend a Washington, D.C. sentencing reform law when his own charge for marijuana possession in his youth was dismissed under a court’s discretion.

The House of Representatives on Tuesday took up bills targeting D.C. policies that recently advanced through the Oversight and Government Accountability. That included a measure titled the DC Crimes Act from Rep. Byron Donalds (R-FL), which would restrict the District’s ability to enact sentencing reform.

Rep. Jasmine Crockett (D-TX) said the GOP congressman’s push for the legislation represents a double standard given his own personal history with cannabis criminalization as a young adult and whose case was dismissed, enabling him to reach Capitol Hill.

“As a young man, he went through pretrial diversion for misdemeanor marijuana possession,” Crockett said. “As an adult yet younger than 24, he was placed on felony robbery charges, which ultimately, too, were expunged.”

“As I sat and listened to the beginning of this debate, my heart simply broke. And many people know me for being able to do alliterations, and all I could think about was ‘amnesia allows adolescent accountability avoidance, agility from across the aisle,’” she said.

“Work with me for a second: Imagine being a young man born to Jamaican and Panamanian parents who messed up not once but twice. Imagine standing in front of a judge with your life hanging in balance, and instead of prison you’re given a promise of mercy. Your record is wiped clean, and you’ve got a second chance at life. Imagine turning that into a promotion and you go to college and get a job and even become a member of Congress. That’s what redemption looks like.”

“That’s what America is supposed to be about. And that is exactly the story of the next wannabe governor from Florida, as a young man, he went through,” the congresswoman said, referring to Donalds.

Keep reading

The Return of Drug War Imperialism

The Trump administration is escalating U.S. drug wars in Latin America as a cover for imperialism.

While the administration directs a military buildup in the Caribbean, killing people who it claims are drug smugglers, it is preparing to intervene in Latin American countries for the purpose of opening their markets to U.S. businesses. The administration’s priority is gaining access to Latin American resources, a main focus of its foreign policy, just as the highest-level officials have indicated.

“Increasingly, on geopolitical issue after geopolitical issue, it is access to raw material and industrial capacity that is at the core both of the decisions that we’re making and the areas that we’re prioritizing,” Secretary of State Marco Rubio said in June.

Drug War Imperialism

One of the major contributions of the United States to imperial history is drug war imperialism. Developed as part of the so-called “war on drugs,” which the Nixon administration began in the 1970s and the Reagan administration expanded in the 1980s, drug war imperialism has been one of the primary means by which the United States has intervened in Latin America.

During the late 1980s, the United States set the standard for drug war imperialism in Panama. After discrediting Manuel Noriega with drug charges, officials in Washington organized a military intervention to remove the Panamanian ruler from power.

Under the direction of the George H. W. Bush administration, the U.S. military invaded Panama, captured Noriega, and brought him to the United States, where he was tried, convicted, and imprisoned on drug charges. U.S. officials framed the operation as part of the war on drugs, but their primary concern was bringing to power a friendly government that acted on behalf of U.S. interests. U.S. officials valued Panama for its location and for the Panama Canal, a critical node for U.S. trade.

In the following decades, the United States exercised other forms of drug war imperialism in Latin America. In 2000, the administration of Bill Clinton implemented Plan Colombia, a program of U.S. military support for the Colombian government. U.S. officials framed Plan Colombia as a counter-narcotics program, but their objective was to empower the Colombian military in its war against leftist revolutionaries, especially the Revolutionary Armed Forces of Colombia (FARC).

In 2007, the administration of George W. Bush pushed forward a similar program in Mexico. With the Mérida Initiative, the Bush administration empowered the Mexican government to intensify its war against drug cartels. U.S. officials saw the program as way to forge closer relations with the Mexican military and confront the country’s drug traffickers, who were making it difficult for U.S. businesses to operate in the country.

Multiple administrations faced strong criticisms over the programs, especially as drug-related violence increased in Colombia and Mexico. A Colombian truth commission estimated that 450,000 people were killed in Colombia from 1985 to 2018, with 80 percent of the deaths being civilians. There have been hundreds of thousands of drug-related deaths in Mexico, with the numbers still increasing by tens of thousands every year.

Although most U.S. officials insisted that criminal organizations in Latin America bore primary responsibility for drug-related violence, some began to question the U.S. approach. They wondered whether U.S.-backed drug wars were ignoring root causes of the drug problem, such as the U.S. demand for drugs.

“As Americans we should be ashamed of ourselves that we have done almost nothing to get our arms around drug demand,” Secretary of Homeland Security John Kelly said in 2017. “And we point fingers at people to the south and tell them they need to do more about drug production and drug trafficking.”

In recent years, some critics have even cast the drug wars as a failure. Decades of U.S.-backed military operations, they have noted, have brought terrible violence to Latin America while failing to stop the flow of drugs to the United States.

“Drugs have kept flowing, and Americans and Latin Americans have kept dying,” Shannon O’Neil, who chaired a congressionally-mandated drug policy commission, told Congress in 2020. “Something is not working.”

Keep reading

Marijuana Industry Group Pushes Congress For Tax Relief—And To Apply The Fix Retroactively For Past Payments

A leading marijuana industry association has released a report calling on Congress to treat cannabis businesses like other lawful industries by allowing them to take federal tax deductions—and also to apply that policy retroactively to provide relief for past payments.

The report from the National Cannabis Industry Association (NCIA) and a coalition of stakeholders states that “no industry understands the pain of taxes as acutely as the state-regulated cannabis industry which currently pays draconian tax rates as a result of the unforeseen consequences of” an Internal Revenue Service (IRS) code known as 280E.

That code precludes even state-licensed marijuana businesses from taking federal deductions for their expenses because cannabis remains a Schedule I drug under the Controlled Substances Act (CSA).

“This provision is a punitive poison pill that threatens every business in these state-regulated markets, but poses a particular threat to small businesses that have responded to the will of voters,” the report says. “Picture the medical dispensary serving veterans with an alternative to deadly opioids or providing comfort to cancer patients in your community: those businesses cannot survive without action to repeal §280E and, crucially, retroactive relief.”

NCIA says the costs of the IRS policy for the cannabis sector are “staggering,” with marijuana businesses paying an effective tax rate of more than 70 percent. That rate “is economically prohibitive, unsustainable, and counter-intuitive,” it says.

“In the cruelest of ironies, the failure to include retroactive relief for state-regulated cannabis businesses will fall primarily on two groups: small cannabis businesses located in early legalization states and equity-owned businesses provided state-licensing priority specifically because of injuries suffered as a result of cannabis prohibition.”

Notably, NCIA stressed that tax relief for the marijuana industry should be applied retroactively. Without that stipulation, the association said “taxes will continue to result in the closure and consolidation of many state-regulated small businesses.”

“Beyond having negative economic impacts, inaction will also harm public health by forcing consumers back to the untaxed, untested, and unregulated illicit market,” it said.

Keep reading

Lawmakers Debate Whether Marijuana Legalization Helps Or Hurts Organized Crime At Hearing On Chinese-Linked Illicit Grows

A GOP-led House committee held a hearing on Thursday focused on Chinese criminal organizations behind large-scale illicit marijuana grows, taking testimony from a group of law enforcement officials and a researcher who each attempted to link the issue to state-level legalization.

But one Democratic lawmaker took the opportunity to make the case for cannabis rescheduling and broader federal reform to mitigate the issue.

The House Homeland Security Subcommittee on Oversight, Investigations, & Accountability hearing was titled “Invasion of the Homeland: How China is Using Illegal Marijuana to Build a Criminal Network Across America.”

While there was some talk among experts and lawmakers about differentiating state-sanctioned cannabis cultivation from the illicit market, the conversation largely skewed prohibitionist. Witnesses included a former Drug Enforcement Administration (DEA) agent, top Oklahoma law enforcement official and a researcher with the conservative Heritage Foundation think tank.

The subcommittee chairman, Rep. Josh Brecheen (R-OK) said in his opening remarks that “we’ve enabled these foreign organizations with potential links to the [Chinese Community Party, or CCP] to build up a sophisticated network throughout the United States, which facilitates a wide range of other criminal activity and presents a national security threat.”

“This is a convergence of organized crime, human drug trafficking, public health risks—all operating at scale and sophistication crossing the state national lines beyond the normal capabilities of state and local law enforcement to combat,” he said. “These agencies need the help of federal law enforcement to unravel these criminal networks.”

Rep. Troy Carter (D-LA), however, spoke about the collateral consequences of prohibition, saying the “federal government’s decision to criminalize marijuana has been nothing short of disastrous for our communities, for our economy and for justice in America.”

“The failed war against cannabis has especially devastated Black and brown communities. Arrest and incarceration rates for marijuana offenses have been wildly disproportionate,” he said. “Today, with most Americans supporting legalization, it is past time that we acknowledge the truth: Marijuana prohibition has failed.”

“If we want to dismantle foreign criminal networks and protect American communities, then we need to strengthen, not weaken, regulated markets,” Carter said.

Keep reading

President Trump Rebukes Colombia Over Drug Trafficking Cooperation

The United States has placed Colombia on its list of countries that “fail to co-operate” in fighting drug trafficking — the first time since 1997 — blaming President Gustavo Petro’s government for record cocaine output, according to the Financial Times.

In a statement to Congress, Donald Trump said Colombia’s “coca cultivation and cocaine production have reached record highs” and that the government “failed to meet even its own vastly reduced coca eradication goals.” He argued Bogotá had undermined “years of mutually beneficial co-operation between our two countries against narco-terrorists.”

Colombia, the world’s top cocaine producer, had 253,000 hectares of coca under cultivation in 2023, yielding more than 2,600 tonnes, according to UN figures.

Petro, a former guerrilla who has floated legalising cocaine, denounced the US move: “Decades of our police, soldiers and civilians [dying] . . . in order to stop drugs reaching North American society,” he said, insisting “Everything we do really isn’t about the Colombian people — even if they get affected. It’s about stopping North American society from smearing its noses.”

The Financial Times writes that while criticising Petro’s approach, Trump praised Colombia’s security forces, who he said “continue to show skill and courage in confronting terrorist and criminal groups.” Washington also issued a waiver allowing continued programs that “advance US interests,” potentially preserving military co-operation.

The move reflects rising tensions. For years, Colombia was Washington’s closest anti-narcotics ally, receiving more than $10bn in US military aid under Plan Colombia (2000–2016). But Petro has shifted focus from eradication campaigns to intercepting drug shipments at sea, while violence and production have grown under his “Total Peace” policy.

Keep reading

FDA Warns Companies Against False and Misleading Drug Ads

Federal regulators sent dozens of letters to companies in September warning them that their advertisements for drugs are misleading and could lead to repercussions unless fixed.

The Food and Drug Administration on Sept. 16 released 65 letters it sent on Sept. 9 to companies, including Eli Lilly and Novo Nordisk. President Donald Trump signed a memorandum that day directing officials to enforce existing rules surrounding direct-to-consumer advertising for drugs.

In letters to Eli Lilly, FDA officials said that advertisements for weight loss products, including one that originally appeared in a special held by Oprah Winfrey, did not present people with accurate information about possible side effects.

The ad that aired during the Oprah special “creates a misleading impression regarding the safety of Zepbound and Mounjaro, which are drugs with multiple serious, potentially life threatening risks,” officials with the FDA’s Center for Drug Evaluation and Research said in one of the letters. They said that people who seek medical treatment for obesity or Type 2 diabetes “should receive truthful and non-misleading information.”

An Eli Lilly spokesperson told The Epoch Times in an email: “FDA’s correspondence to Lilly addresses three interviews conducted by independent media outlets. These interviews were not advertisements, and Lilly had no editorial control over them.

“We remain committed to providing patients with accurate, reliable information that empowers them to make informed healthcare decisions in partnership with their physicians.”

Keep reading

Legalizing Medical Marijuana Is Linked To Reduced Use Of Tobacco And Amphetamines, New International Study Shows

There’s a “strong negative association” between tobacco use and legal medical marijuana sales, according to a new international study—indicating a “strong potential substitution effect” where people choose to use cannabis where it is allowed instead of smoking cigarettes.

The study, based on data from 20 countries, also found that amphetamine use is “negatively associated” with medical cannabis sales, “suggesting substitution dynamics.”

The researchers additionally concluded that a “well-regulated [medical cannabis, or MC] market can generate sustained economic benefits, emphasizing the need for comprehensive legal frameworks that address licensing, production standards, and access pathways,” adding that “removing barriers to access and enhancing consumer education will support the development of a responsible and sustainable market.”

The analysis also showed “a sustained growth trajectory” in medical cannabis sales after legalization, finding that the policy change is “associated with an average annual increase of 26.06 tons of MC sales in legalizing countries.” After excluding the U.S., which the researchers called “a major outlier in market size,” there was “a slightly lower average effect of 20.05,” which “still supports the persistent market expansion.”

The authors, based in Germany and Lebanon, cautioned that “given the ecological nature of the design, these results should be interpreted as population-level associations rather than individual-level causal effect.”

“Nonetheless, they highlight the potential economic relevance of cannabis legalization in expanding regulated markets and reshaping consumer behavior,” the paper says. “The study contributes to debates on legalization, public health, and economic policy by providing empirical evidence on the associations between legal reforms and market dynamics.”

The study comes amid new research indicating that marijuana use is linked to lower alcohol intake and diminished cravings in heavy drinkers, according to a new federally funded scientific paper.

Keep reading